Brand | Rcnet |
Composition | sunitinib malate |
Manufacturer | BDR Pharmaceuticals Intl. Pvt. Ltd. |
Treatment | renal cell carcinoma and pancreatic neuroendocrine tumor |
Form | Capsules |
Sunitinib Capsule is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor. Sunitinib Capsules is used for the treatment of treatment of gastrointestinal stromal tumor (GIST), advanced renal cell cancer, advanced pancreatic neuroendocrine tumor.
Exports To: Uzbekistan | Morocco | Zambia | Greece | Lebanon
Brand | Rcnet |
Composition | sunitinib malate |
Manufacturer | BDR Pharmaceuticals Intl. Pvt. Ltd. |
Treatment | renal cell carcinoma and pancreatic neuroendocrine tumor |
Form | Capsules |
Strength | 12.5mg |
Country of Origin | Made in India |
Delivery Time | 24 - 48 hours |
A-706,7th Floor, Winsway Complex , Andheri East Mumbai - 400058, Maharashtra, India
Get DirectionsHave a requirement?
Chat with us
Have a requirement?
Chat with us